We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Inviragen and Duke-NUS Form Collaborative Vaccine Research and Development Program

News   Jan 27, 2011

 
Inviragen and Duke-NUS Form Collaborative Vaccine Research and Development Program
 
 
Advertisement
 

RELATED ARTICLES

SARS-CoV-2 Spike Protein Structurally Characterized – Along With Its Relative

News

Researchers at the Francis Crick Institute have characterized the structure of the SARS-CoV-2 spike protein as well as its most similar relative in a bat coronavirus. The structures provide clues about how the spike evolved and could help inform vaccine design.

READ MORE

New Cancer Vaccine Ready for Human Trials

News

A new cancer vaccine, comprised of human antibodies fused with tumor-specific protein, is ready to begin human testing.

READ MORE

Computer Model Helps To Improve Injectability of Drug-delivering Particles

News

Researchers have developed a computational model that helps improve the injectability of microparticles and prevent them from clogging.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE